Jeffrey K Tong

CIK 1479701 · VP, Cor. & Product Development · last filed 2025-06-20

Jeffrey K Tong is a VP, Cor. & Product Development who has filed 3 SEC Form 4 insider transactions across 3 companies since 2010. The most recent filing, for SEPN, was dated Jun 20, 2025.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

3

Total Filings

3

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SEPN	Director	—	$35.95	—	$0	1	2025-06-20
NRIX	Director	—	$16.95	—	$0	1	2021-05-24
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted	VP, Cor. & Product Development	—	$0.04	—	$0	1	2010-01-07

Recent Filings

3 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2025-06-20	SEPN	Grant (A)	—	$0	EDGAR
2021-05-24	NRIX	Grant (A)	—	$0	EDGAR
2010-01-07	INFINITY PHARMACEUTICALS, INC. (INFI) Delisted	Grant (A)	—	$0	EDGAR

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.